Latest evidence update: 2025-11-11
Strongest in Sample size (85). Held back by Recency (41).
Solid mix of RCTs with some methodological gaps.
Confirmed across many independent studies with significant findings.
Tens of thousands of participants pooled across studies.
Studies agree on direction of effect.
Evidence base skews older; field may have moved on.
Effect-size tagged on 997 of 1000 claims for this food. Our research updates daily; remaining claims are pending re-processing.
Areas where research points to a consistent direction of effect. The strength of evidence is graded; the size of the effect is not quantified.
Compound-by-compound profile of what's in this food and the evidence behind each.
100g
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.
Guggulu, garlic, and black cumin demonstrated a moderate to high level of evidence for efficacy in reducing hypercholesterolemia across 32 randomized controlled trials.
Black cumin lowered total cholesterol levels by 9.28 mg/dL in individuals with hypercholesterolemia.
Guggulu, garlic, and black cumin demonstrated minimal adverse side effects in individuals with hypercholesterolemia.
Curcumin and its derivatives demonstrate significant in vitro and in vivo antileishmanial activity against different Leishmania species.
Curcumin and its derivatives exhibited no significant toxicity in the reviewed studies.